{"id":"https://openalex.org/W2144643134","doi":"https://doi.org/10.1128/aac.01145-08","title":"Intracellular Activity of Antibiotics in a Model of Human THP-1 Macrophages Infected by a Staphylococcus aureus Small-Colony Variant Strain Isolated from a Cystic Fibrosis Patient: Pharmacodynamic Evaluation and Comparison with Isogenic Normal-Phenotype and Revertant Strains","display_name":"Intracellular Activity of Antibiotics in a Model of Human THP-1 Macrophages Infected by a Staphylococcus aureus Small-Colony Variant Strain Isolated from a Cystic Fibrosis Patient: Pharmacodynamic Evaluation and Comparison with Isogenic Normal-Phenotype and Revertant Strains","alternate_titles":[],"publication_year":2009,"publication_date":"2009-02-03","ids":{"openalex":"https://openalex.org/W2144643134","doi":"https://doi.org/10.1128/aac.01145-08","mag":"2144643134","pmid":"https://pubmed.ncbi.nlm.nih.gov/19188393","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/2663071"},"language":"en","primary_location":{"id":"doi:10.1128/aac.01145-08","doi":"https://doi.org/10.1128/aac.01145-08","is_oa":false,"landing_page_url":"https://doi.org/10.1128/aac.01145-08","pdf_url":null,"source":{"id":"https://openalex.org/S47215897","display_name":"Antimicrobial Agents and Chemotherapy","issn_l":"0066-4804","issn":["0066-4804","1070-6283","1098-6596"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320263","host_organization_name":"American Society for Microbiology","host_organization_lineage":["https://openalex.org/P4310320263"],"host_organization_lineage_names":["American Society for Microbiology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial Agents and Chemotherapy","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2144643134"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC2663071/","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101797172","display_name":"Hoang Anh Nguyen","orcid":"https://orcid.org/0000-0002-9643-1678","observed_orcids":["https://orcid.org/0000-0002-9643-1678"]},"institutions":[{"id":"https://openalex.org/I95674353","display_name":"UCLouvain","ror":"https://ror.org/02495e989","country_code":"BE","type":"education","lineage":["https://openalex.org/I95674353"]}],"countries":["BE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Hoang Anh Nguyen","raw_affiliation_strings":["Universite\u0301 Catholique de Louvain, Louvain Drug Research Institute, Unite\u0301 de Pharmacologie Cellulaire et Mole\u0301culaire"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universite\u0301 Catholique de Louvain, Louvain Drug Research Institute, Unite\u0301 de Pharmacologie Cellulaire et Mole\u0301culaire","institution_ids":["https://openalex.org/I95674353"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102956869","display_name":"Olivier Denis","orcid":"https://orcid.org/0000-0003-1200-7552","observed_orcids":["https://orcid.org/0000-0003-1200-7552"]},"institutions":[{"id":"https://openalex.org/I2802054198","display_name":"Erasmus Hospital","ror":"https://ror.org/05j1gs298","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I2802054198"]}],"countries":["BE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Olivier Denis","raw_affiliation_strings":["Ho\u0302pital Erasme, Department of Microbiology, Laboratoire de Re\u0301fe\u0301rence MRSA-Staphylocoques"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ho\u0302pital Erasme, Department of Microbiology, Laboratoire de Re\u0301fe\u0301rence MRSA-Staphylocoques","institution_ids":["https://openalex.org/I2802054198"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109211826","display_name":"Anne Vergison","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210108467","display_name":"Queen Fabiola Children's University Hospital","ror":"https://ror.org/01t5yh786","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I4210108467"]}],"countries":["BE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Anne Vergison","raw_affiliation_strings":["Ho\u0302pital des Enfants Reine Fabiola, De\u0301partement de Maladies Infectieuses Pe\u0301diatriques"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ho\u0302pital des Enfants Reine Fabiola, De\u0301partement de Maladies Infectieuses Pe\u0301diatriques","institution_ids":["https://openalex.org/I4210108467"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032938680","display_name":"Anne Theunis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I132053463","display_name":"Universit\u00e9 Libre de Bruxelles","ror":"https://ror.org/01r9htc13","country_code":"BE","type":"education","lineage":["https://openalex.org/I132053463"]},{"id":"https://openalex.org/I4210102955","display_name":"Centre Hospitalier Universitaire Brugmann","ror":"https://ror.org/011apjk30","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I4210102955"]},{"id":"https://openalex.org/I4210154425","display_name":"Centre Hospitalier Universitaire de Saint-Pierre","ror":"https://ror.org/05cmp5q80","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I4210154425"]}],"countries":["BE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Anne Theunis","raw_affiliation_strings":["CHU Saint Pierre-Huderf-CHU Brugmann, De\u0301partement Interhospitalier de Dermatologie, Universite\u0301 Libre de Bruxelles, Brussels, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CHU Saint Pierre-Huderf-CHU Brugmann, De\u0301partement Interhospitalier de Dermatologie, Universite\u0301 Libre de Bruxelles, Brussels, Belgium","institution_ids":["https://openalex.org/I132053463","https://openalex.org/I4210102955","https://openalex.org/I4210154425"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004434922","display_name":"Paul M. Tulkens","orcid":"https://orcid.org/0000-0002-7121-3623","observed_orcids":["https://orcid.org/0000-0002-7121-3623"]},"institutions":[{"id":"https://openalex.org/I95674353","display_name":"UCLouvain","ror":"https://ror.org/02495e989","country_code":"BE","type":"education","lineage":["https://openalex.org/I95674353"]}],"countries":["BE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Paul M. Tulkens","raw_affiliation_strings":["Universite\u0301 Catholique de Louvain, Louvain Drug Research Institute, Unite\u0301 de Pharmacologie Cellulaire et Mole\u0301culaire"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universite\u0301 Catholique de Louvain, Louvain Drug Research Institute, Unite\u0301 de Pharmacologie Cellulaire et Mole\u0301culaire","institution_ids":["https://openalex.org/I95674353"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043496834","display_name":"Marc Jean Struelens","orcid":"https://orcid.org/0000-0001-5150-4944","observed_orcids":["https://orcid.org/0000-0001-5150-4944"]},"institutions":[{"id":"https://openalex.org/I2802054198","display_name":"Erasmus Hospital","ror":"https://ror.org/05j1gs298","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I2802054198"]}],"countries":["BE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Marc J. Struelens","raw_affiliation_strings":["Ho\u0302pital Erasme, Department of Microbiology, Laboratoire de Re\u0301fe\u0301rence MRSA-Staphylocoques"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ho\u0302pital Erasme, Department of Microbiology, Laboratoire de Re\u0301fe\u0301rence MRSA-Staphylocoques","institution_ids":["https://openalex.org/I2802054198"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5019102142","display_name":"Fran\u00e7oise Van Bambeke","orcid":"https://orcid.org/0000-0002-0052-7991","observed_orcids":["https://orcid.org/0000-0002-0052-7991"]},"institutions":[{"id":"https://openalex.org/I95674353","display_name":"UCLouvain","ror":"https://ror.org/02495e989","country_code":"BE","type":"education","lineage":["https://openalex.org/I95674353"]}],"countries":["BE"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Franc\u0327oise Van Bambeke","raw_affiliation_strings":["Universite\u0301 Catholique de Louvain, Louvain Drug Research Institute, Unite\u0301 de Pharmacologie Cellulaire et Mole\u0301culaire"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universite\u0301 Catholique de Louvain, Louvain Drug Research Institute, Unite\u0301 de Pharmacologie Cellulaire et Mole\u0301culaire","institution_ids":["https://openalex.org/I95674353"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5019102142"],"corresponding_institution_ids":["https://openalex.org/I95674353"],"apc_list":null,"apc_paid":null,"fwci":3.5149,"has_fulltext":false,"cited_by_count":69,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.91879356,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"53","issue":"4","first_page":"1434","last_page":"1442"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10195","display_name":"Antimicrobial Resistance in Staphylococcus","score":0.9887999892234802,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10195","display_name":"Antimicrobial Resistance in Staphylococcus","score":0.9887999892234802,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10593","display_name":"Bacterial biofilms and quorum sensing","score":0.004000000189989805,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.0034000000450760126,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cystic-fibrosis","display_name":"cystic fibrosis","score":0.7720000147819519},{"id":"https://openalex.org/keywords/thp-1-macrophages","display_name":"THP-1 macrophages","score":0.9520000219345093},{"id":"https://openalex.org/keywords/antibiotic-susceptibility","display_name":"antibiotic susceptibility","score":0.6700000166893005},{"id":"https://openalex.org/keywords/oritavancin","display_name":"oritavancin","score":0.9120000004768372},{"id":"https://openalex.org/keywords/tigecycline","display_name":"tigecycline","score":0.9639999866485596},{"id":"https://openalex.org/keywords/moxifloxacin","display_name":"moxifloxacin","score":0.8119999766349792},{"id":"https://openalex.org/keywords/quinupristin-dalfopristin","display_name":"quinupristin/dalfopristin","score":0.9150000214576721},{"id":"https://openalex.org/keywords/bacterial-persistence","display_name":"bacterial persistence","score":0.5400000214576721}],"concepts":[{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.7613458633422852},{"id":"https://openalex.org/C2781414143","wikidata":"https://www.wikidata.org/wiki/Q411377","display_name":"Linezolid","level":5,"score":0.759276807308197},{"id":"https://openalex.org/C2777027569","wikidata":"https://www.wikidata.org/wiki/Q420595","display_name":"Tigecycline","level":3,"score":0.5770277976989746},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.5636965036392212},{"id":"https://openalex.org/C2780483375","wikidata":"https://www.wikidata.org/wiki/Q259930","display_name":"Fusidic acid","level":4,"score":0.5496184229850769},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4710889756679535},{"id":"https://openalex.org/C2779489039","wikidata":"https://www.wikidata.org/wiki/Q188121","display_name":"Staphylococcus aureus","level":3,"score":0.46184271574020386},{"id":"https://openalex.org/C2778980435","wikidata":"https://www.wikidata.org/wiki/Q424027","display_name":"Vancomycin","level":4,"score":0.42748844623565674},{"id":"https://openalex.org/C523546767","wikidata":"https://www.wikidata.org/wiki/Q10876","display_name":"Bacteria","level":2,"score":0.16256704926490784},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D002460","descriptor_name":"Cell Line","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003550","descriptor_name":"Cystic Fibrosis","qualifier_ui":"Q000382","qualifier_name":"microbiology","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005672","descriptor_name":"Fusidic Acid","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005839","descriptor_name":"Gentamicins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008264","descriptor_name":"Macrophages","qualifier_ui":"Q000382","qualifier_name":"microbiology","is_major_topic":true},{"descriptor_ui":"D008826","descriptor_name":"Microbial Sensitivity Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010068","descriptor_name":"Oxacillin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010641","descriptor_name":"Phenotype","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011485","descriptor_name":"Protein Binding","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013211","descriptor_name":"Staphylococcus aureus","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D013936","descriptor_name":"Thymidine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false}],"locations_count":6,"locations":[{"id":"doi:10.1128/aac.01145-08","doi":"https://doi.org/10.1128/aac.01145-08","is_oa":false,"landing_page_url":"https://doi.org/10.1128/aac.01145-08","pdf_url":null,"source":{"id":"https://openalex.org/S47215897","display_name":"Antimicrobial Agents and Chemotherapy","issn_l":"0066-4804","issn":["0066-4804","1070-6283","1098-6596"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320263","host_organization_name":"American Society for Microbiology","host_organization_lineage":["https://openalex.org/P4310320263"],"host_organization_lineage_names":["American Society for Microbiology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial Agents and Chemotherapy","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:2663071","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC2663071/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrob Agents Chemother","raw_type":"Text"},{"id":"pmid:19188393","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19188393","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial agents and chemotherapy","raw_type":"Comparative Study"},{"id":"pmh:oai:dipot.ulb.ac.be:2013/84349","doi":null,"is_oa":false,"landing_page_url":"https://dipot.ulb.ac.be/dspace/bitstream/2013/84349/4/PMC2663071.pdf","pdf_url":"https://dipot.ulb.ac.be/dspace/bitstream/2013/84349/4/PMC2663071.pdf","source":{"id":"https://openalex.org/S4306401063","display_name":"D\u00e9p\u00f4t institutionnel de l'Universit\u00e9 libre de Bruxelles (Universit\u00e9 Libre de Bruxelles)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I132053463","host_organization_name":"Universit\u00e9 Libre de Bruxelles","host_organization_lineage":["https://openalex.org/I132053463"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Antimicrobial agents and chemotherapy, 53 (4","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:dial.uclouvain.be:boreal:21422","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/2078.1/21422","pdf_url":null,"source":{"id":"https://openalex.org/S4306401974","display_name":"DIAL (Catholic University of Leuven)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I99464096","host_organization_name":"KU Leuven","host_organization_lineage":["https://openalex.org/I99464096"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Antimicrobial Agents and Chemotherapy, Vol. 53, no. 4, p. 1434-1442 (2009)","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.521.5404","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.521.5404","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://www.farm.ucl.ac.be/Full-texts-FARM/Nguyen-2009-1.pdf","raw_type":"text"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:2663071","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC2663071/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrob Agents Chemother","raw_type":"Text"},"sustainable_development_goals":[{"score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":60,"referenced_works":["https://openalex.org/W1581962345","https://openalex.org/W1761247443","https://openalex.org/W1833207062","https://openalex.org/W1971145915","https://openalex.org/W1975789761","https://openalex.org/W1983269321","https://openalex.org/W1986308514","https://openalex.org/W2005955658","https://openalex.org/W2017945759","https://openalex.org/W2021839962","https://openalex.org/W2022839004","https://openalex.org/W2027373007","https://openalex.org/W2028288720","https://openalex.org/W2034443922","https://openalex.org/W2038716450","https://openalex.org/W2062689424","https://openalex.org/W2079774537","https://openalex.org/W2088960594","https://openalex.org/W2096996011","https://openalex.org/W2097659626","https://openalex.org/W2100822650","https://openalex.org/W2109132453","https://openalex.org/W2109148450","https://openalex.org/W2114483666","https://openalex.org/W2114601507","https://openalex.org/W2114660268","https://openalex.org/W2116900840","https://openalex.org/W2117266992","https://openalex.org/W2117449266","https://openalex.org/W2118965502","https://openalex.org/W2119509323","https://openalex.org/W2130101808","https://openalex.org/W2135746315","https://openalex.org/W2137092505","https://openalex.org/W2137448773","https://openalex.org/W2138731773","https://openalex.org/W2142711585","https://openalex.org/W2144240948","https://openalex.org/W2147723850","https://openalex.org/W2147796198","https://openalex.org/W2149586621","https://openalex.org/W2150783010","https://openalex.org/W2151124149","https://openalex.org/W2151722492","https://openalex.org/W2152594398","https://openalex.org/W2152793156","https://openalex.org/W2157817566","https://openalex.org/W2158199036","https://openalex.org/W2158467440","https://openalex.org/W2159366663","https://openalex.org/W2160422895","https://openalex.org/W2161808188","https://openalex.org/W2162573988","https://openalex.org/W2163233110","https://openalex.org/W2164524532","https://openalex.org/W2168444466","https://openalex.org/W2168765004","https://openalex.org/W2169705111","https://openalex.org/W2498908469","https://openalex.org/W2970730326"],"related_works":["https://openalex.org/W7097698237","https://openalex.org/W7095149145","https://openalex.org/W2165773062","https://openalex.org/W7098955631","https://openalex.org/W2142368206","https://openalex.org/W2188112055","https://openalex.org/W2096404632","https://openalex.org/W1759115430","https://openalex.org/W2126467271"],"abstract_inverted_index":{"Small-colony":[0],"variant":[1],"(SCV)":[2],"strains":[3,56],"of":[4,20,181,194,206,213,218,228,258],"Staphylococcus":[5],"aureus":[6],"show":[7],"reduced":[8],"antibiotic":[9],"susceptibility":[10],"and":[11,34,53,70,73,83,87,112,140,149,161,183,189,200,236],"intracellular":[12,216,240,262],"persistence,":[13],"potentially":[14],"explaining":[15],"therapeutic":[16],"failures.":[17],"The":[18,64,251],"activities":[19],"oxacillin,":[21],"fusidic":[22],"acid,":[23],"clindamycin,":[24],"gentamicin,":[25],"rifampin,":[26,138],"vancomycin,":[27],"linezolid,":[28],"quinupristin-dalfopristin,":[29],"daptomycin,":[30],"tigecycline,":[31,100,187],"moxifloxacin,":[32,139,188],"telavancin,":[33],"oritavancin":[35,129,175],"have":[36],"been":[37],"examined":[38],"in":[39,49,77,93,105,124],"THP-1":[40],"macrophages":[41],"infected":[42],"by":[43],"a":[44,102,131,143,155,162],"stable":[45],"thymidine-dependent":[46],"SCV":[47,65,86,220,249,263],"strain":[48,66,221],"comparison":[50],"with":[51,261],"normal-phenotype":[52,89],"revertant":[54,245],"isogenic":[55],"isolated":[57],"from":[58],"the":[59,88,121,201,219,226,256],"same":[60],"cystic":[61],"fibrosis":[62],"patient.":[63],"grew":[67],"slowly":[68],"extracellularly":[69],"intracellularly":[71],"(1-":[72],"0.2-log":[74],"CFU":[75,133,164,209],"increase":[76],"24":[78,136,159],"h,":[79],"respectively).":[80],"In":[81,169],"confocal":[82],"electron":[84],"microscopy,":[85],"bacteria":[90],"remain":[91],"confined":[92],"acid":[94],"vacuoles.":[95],"All":[96,232],"antibiotics":[97,152,203,229],"tested,":[98],"except":[99],"caused":[101,130,142],"net":[103],"reduction":[104,134,145,165],"bacterial":[106],"counts":[107],"that":[108],"was":[109,176],"both":[110],"time":[111],"concentration":[113,118,123,170],"dependent.":[114],"At":[115],"an":[116],"extracellular":[117],"corresponding":[119],"to":[120,174,196],"maximum":[122],"human":[125],"serum":[126],"(total":[127],"drug),":[128],"2-log":[132],"at":[135,146,158,166],"h;":[137,148],"quinupristin-dalfopristin":[141],"similar":[144],"72":[147,167],"all":[150],"other":[151,202],"had":[153],"only":[154],"static":[156],"effect":[157],"h":[160],"1-log":[163],"h.":[168],"dependence":[171],"experiments,":[172],"response":[173],"bimodal":[177],"(two":[178],"successive":[179],"plateaus":[180],"-0.4":[182],"-3.1":[184],"log":[185,198,208],"CFU);":[186],"rifampin":[190],"showed":[191,238],"maximal":[192],"effects":[193],"-1.1":[195],"-1.7":[197],"CFU;":[199],"produced":[204],"results":[205],"-0.6":[207],"or":[210,244],"less.":[211],"Addition":[212],"thymidine":[214],"restored":[215],"growth":[217],"but":[222],"did":[223],"not":[224],"modify":[225],"activity":[227,241],"(except":[230,234],"quinupristin-dalfopristin).":[231],"drugs":[233],"tigecycline":[235],"oritavancin)":[237],"higher":[239],"against":[242,248],"normal":[243],"phenotypes":[246],"than":[247],"strains.":[250,264],"data":[252],"may":[253],"help":[254],"rationalizing":[255],"design":[257],"further":[259],"studies":[260]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2144643134","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":6},{"year":2015,"cited_by_count":7},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":5}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
